Clinical Trial Update: Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating methyl aminolevulinate photodynamic therapy with and without Er:YAG laser for Bowen's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bowen Disease

Drugs mentioned

• Methyl aminolevulinate (methyl aminolevulinate)

Snippet

Sponsor: Dong-A University | Conditions: Bowen's Disease | Phase 1 | Status: COMPLETED